Contravisory Investment Management, Inc. Mirum Pharmaceuticals, Inc. Transaction History
Contravisory Investment Management, Inc.
- $483 Million
- Q2 2025
A detailed history of Contravisory Investment Management, Inc. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Contravisory Investment Management, Inc. holds 5,307 shares of MIRM stock, worth $267,844. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,307Holding current value
$267,844% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
228Shares Held
55.4MCall Options Held
27.4KPut Options Held
105K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.8MShares$343 Million19.27% of portfolio
-
Janus Henderson Group PLC London, X04.77MShares$241 Million0.12% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$163 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$141 Million5.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$128 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.85B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...